| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.9 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.9 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |